Skip to content
TrialScanner

NCT05193409

A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety Disorder

Phase 2CompletedNEUPLead

Registry record

Lead sponsor
Bionomics Limited
Conditions
Social Anxiety Disorder
Primary completion
Oct 10, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05193409 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05193409: A Phase 2 Study of BNC210... | TrialScanner